Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Long-Term Deferred Tax: 2016-2020

  • ENDRA Life Sciences' Long-Term Deferred Tax rose 44.32% to $11.3 million in Q4 2020 from the same period last year, while for Dec 2020 it was $11.3 million, marking a year-over-year increase of 44.32%. This contributed to the annual value of $11.3 million for FY2020, which is 44.32% up from last year.
  • Latest data reveals that ENDRA Life Sciences reported Long-Term Deferred Tax of $11.3 million as of Q4 2020, which was up 44.32% from $7.8 million recorded in Q4 2019.
  • In the past 5 years, ENDRA Life Sciences' Long-Term Deferred Tax ranged from a high of $11.3 million in Q4 2020 and a low of $3.8 million during Q4 2016.
  • Moreover, its 3-year median value for Long-Term Deferred Tax was $7.8 million (2019), whereas its average is $8.6 million.
  • Data for ENDRA Life Sciences' Long-Term Deferred Tax shows a peak YoY spiked of 64.12% (in 2018) over the last 5 years.
  • Over the past 5 years, ENDRA Life Sciences' Long-Term Deferred Tax (Quarterly) stood at $3.8 million in 2016, then grew by 5.75% to $4.0 million in 2017, then soared by 64.12% to $6.6 million in 2018, then climbed by 18.49% to $7.8 million in 2019, then skyrocketed by 44.32% to $11.3 million in 2020.
  • Its Long-Term Deferred Tax was $11.3 million in Q4 2020, compared to $7.8 million in Q4 2019 and $6.6 million in Q4 2018.